HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mônica R Gadelha Selected Research

Acromegaly

5/2022Innovative therapeutics in acromegaly.
1/2022Pituitary MRI Features in Acromegaly Resulting From Ectopic GHRH Secretion From a Neuroendocrine Tumor: Analysis of 30 Cases.
1/2022Acromegaly and Colorectal Neoplasm: An Update.
10/2021Growth hormone-releasing hormone-secreting pulmonary neuroendocrine tumor associated with pituitary hyperplasia and somatotropinoma.
9/2021gsp Mutation Is Not a Molecular Biomarker of Long-Term Response to First-Generation Somatostatin Receptor Ligands in Acromegaly.
8/2021New and emerging pharmacological treatment options for acromegaly.
12/2020Risk factors and management of pasireotide-associated hyperglycemia in acromegaly.
12/2020Novel therapies for acromegaly.
6/2020Pasireotide for acromegaly: long-term outcomes from an extension to the Phase III PAOLA study.
1/2019Clinical significance of filamin A in patients with acromegaly and its association with somatostatin and dopamine receptor profiles.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mônica R Gadelha Research Topics

Disease

35Acromegaly
05/2022 - 06/2005
22Neoplasms (Cancer)
10/2022 - 03/2004
8Pituitary Neoplasms (Pituitary Adenoma)
01/2021 - 11/2005
5Adenoma (Adenomas)
11/2020 - 06/2009
4Cushing Syndrome
10/2022 - 01/2009
3Hyperglycemia
10/2022 - 01/2016
3Headache (Headaches)
01/2022 - 03/2004
3Hypertension (High Blood Pressure)
12/2020 - 02/2006
3Pituitary ACTH Hypersecretion
02/2020 - 01/2013
2Hypogonadism (Hypergonadotropic Hypogonadism)
02/2022 - 11/2009
2Carcinoid Tumor (Carcinoid)
11/2021 - 01/2009
2Pituitary Apoplexy
11/2021 - 04/2018
2Hyperplasia
10/2021 - 11/2009
2Prolactinoma (Prolactinomas)
01/2019 - 10/2013
2ACTH-Secreting Pituitary Adenoma
01/2016 - 01/2013
2Residual Neoplasm
05/2015 - 01/2012
2Carcinoma (Carcinomatosis)
11/2013 - 05/2004
2Prostatic Neoplasms (Prostate Cancer)
11/2009 - 11/2009
2Glucose Intolerance
02/2008 - 02/2006
1Mental Disorders (Mental Disorder)
10/2022
1Adrenal Insufficiency (Adrenal Gland Hypofunction)
02/2022
1Pituitary Diseases (Disease, Anterior Pituitary)
02/2022
1Hyperprolactinemia
02/2022
1Opioid-Related Disorders (Opiate Addiction)
02/2022
1Metabolic Diseases (Metabolic Disease)
01/2022
1Neuroendocrine Tumors (Neuroendocrine Tumor)
10/2021
1COVID-19
01/2021
1Dyslipidemias (Dyslipidemia)
12/2020
1Rupture
01/2020
1Craniopharyngioma (Craniopharyngiomas)
01/2020
1Endocrine System Diseases (Endocrine Diseases)
03/2018
1Heart Diseases (Heart Disease)
12/2016
1Lipodystrophy
10/2016
1Fibrosis (Cirrhosis)
12/2015
1Atherosclerosis
10/2015
1Growth Hormone-Secreting Pituitary Adenoma
01/2015
1Diabetes Mellitus
11/2014
1Chronic Disease (Chronic Diseases)
01/2013
1Germinoma
01/2010

Drug/Important Bio-Agent (IBA)

19Octreotide (Sandostatin)FDA LinkGeneric
12/2020 - 03/2004
15Insulin-Like Growth Factor I (IGF-1)IBA
01/2022 - 02/2006
12Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
01/2019 - 06/2005
8Messenger RNA (mRNA)IBA
09/2021 - 01/2007
7pasireotideIBA
10/2022 - 11/2014
7Somatostatin Receptors (Somatostatin Receptor)IBA
09/2021 - 01/2007
6lanreotide (Somatuline)FDA Link
12/2020 - 11/2014
5CabergolineFDA LinkGeneric
10/2022 - 10/2013
5Hormones (Hormone)IBA
01/2022 - 03/2008
5Growth Hormone (Somatotropin)IBA
07/2016 - 03/2004
4Biomarkers (Surrogate Marker)IBA
09/2021 - 01/2016
4LigandsIBA
09/2021 - 01/2018
4Proteins (Proteins, Gene)FDA Link
09/2021 - 01/2015
4Protein Isoforms (Isoforms)IBA
08/2016 - 01/2007
3aryl hydrocarbon receptor-interacting proteinIBA
11/2021 - 01/2011
3Glucose (Dextrose)FDA LinkGeneric
12/2020 - 02/2008
3Dopamine Receptors (Dopamine Receptor)IBA
01/2019 - 06/2009
3Pharmaceutical PreparationsIBA
12/2016 - 03/2004
2Adrenocorticotropic Hormone (ACTH)FDA Link
11/2021 - 01/2009
2pegvisomantFDA LinkGeneric
10/2016 - 06/2014
2beta Carotene (Betacarotene)FDA Link
01/2016 - 01/2013
2LycopeneIBA
01/2016 - 01/2013
2Temozolomide (Temodar)FDA LinkGeneric
11/2013 - 10/2013
2AndrogensIBA
11/2009 - 05/2004
1Opioid Analgesics (Opioids)IBA
02/2022
1Growth Hormone-Releasing Hormone (Somatotropin Releasing Hormone)IBA
10/2021
1GTP-Binding Proteins (G-Protein)IBA
09/2021
1Antiviral Agents (Antivirals)IBA
01/2021
1Telomerase (Telomerase Reverse Transcriptase)IBA
01/2021
1Cyclin AIBA
11/2020
1Hydrocortisone (Cortisol)FDA LinkGeneric
02/2020
1CholesterolIBA
01/2020
1FilaminsIBA
01/2019
1pladienolide BIBA
01/2019
1ArrestinsIBA
01/2018
1EnzymesIBA
10/2016
1Somatotropin Receptors (Growth Hormone Receptor)IBA
08/2016
1Hemostatics (Antihemorrhagics)IBA
10/2015
1ABO Blood-Group SystemIBA
11/2014
1Insulin-Like PeptidesIBA
11/2014
1Ketoconazole (Nizoral)FDA LinkGeneric
01/2014
1MetyraponeFDA Link
01/2014
1Mitotane (Lysodren)FDA Link
01/2014
1Mifepristone (RU 486)FDA Link
01/2014
1ProlactinIBA
10/2013
1Dopamine Agonists (Dopamine Agonist)IBA
10/2013
1somatostatin receptor 2IBA
08/2013
1Keratins (Keratin)IBA
08/2013
1Connexin 43 (Connexin43)IBA
01/2013
1Carotenoids (Carotene)IBA
01/2013
1HydrogelsIBA
11/2012
1Chorionic Gonadotropin (Human Chorionic Gonadotropin)FDA LinkGeneric
01/2010
1alpha-Fetoproteins (alpha-Fetoprotein)IBA
01/2010
1Prostate-Specific Antigen (Semenogelase)IBA
11/2009
1Testosterone (Sustanon)FDA Link
11/2009
1Insulin-Like Growth Factor Binding Protein 3IBA
11/2009

Therapy/Procedure

15Therapeutics
10/2022 - 06/2009
4Radiotherapy
10/2022 - 10/2013
2Precision Medicine
08/2021 - 03/2018
1Procedure Contraindications
10/2022
1Conservative Treatment
04/2018